DATE | EVENT |
March 2 | Review and approval of the draft separate statements and the consolidated statements for the financial year ended 31 December 2021 |
April 28 | Ordinary Shareholders’ Meeting for the approval of the financial statements at 31 december 2021 |
May 4 | Review and approval of the additional periodic financial information* at 31 March 2022 |
August 3 | Review and approval of the 2022 half-year report |
November 3 | Review and approval of the additional periodic financial information* at 30 September 2022 |
* Additional periodic financial information consists in: Revenue by division, Adjusted EBITDA, Adjusted EBIT, EBITDA, EBIT, Operating cash flow, Profit before tax.